Related Experiment Video
Updated: Feb 2, 2026

In vivo 19F MRI for Cell Tracking
Published on: November 25, 2013
Preclinical 19F MRI cell tracking at 3 Tesla
Ashley V Makela1,2, Paula J Foster3,4
1Robarts Research Institute, London, ON, Canada. amakela@uwo.ca.
Purpose:
To develop methods for fluorine-19 (19F) MRI cell tracking in mice on a 3 Tesla clinical scanner. Compared to iron-based cell tracking, 19F MRI has lower sensitivity and, consequently, preclinical 19F cell tracking has only been performed at relatively high magnetic field strengths (> 3 T). Here, we focus on using 19F MRI to detect macrophages in tumors; macrophage density is an indication of tumor aggressiveness and, therefore, 19F MRI could be used as an imaging biomarker.
Methods:
Perfluorocarbon (PFC)-labeled macrophages were imaged at 3 T and NMR spectroscopy was performed to validate 19F spin quantification. In vivo 19F MRI was performed on tumor-bearing mice, post-PFC at both 9.4 T and 3 T. 3 T MRI utilized varying NEX and 19F images were analyzed two different ways for 19F quantification.
Results:
As few as 25,000 cells could be detected as cell pellets at 3 T. 19F quantification in cell pellets by 3 T MRI agreed with NMR spectroscopy. 19F signal was observed in the liver, spleen and tumor in all mice at 9.4 T and 3 T and there was no significant difference in 19F spin quantification.
Conclusion:
This study demonstrates the ability to detect and quantify 19F signal in murine tumors using 19F MRI at 3 T.
Insights
Fluorine-19 (19F) MRI enables cell tracking in tumors at 3 Tesla. This method can detect as few as 25,000 cells, offering a new imaging biomarker for tumor aggressiveness.
Area of Science:
- Biomedical Imaging
- Magnetic Resonance Imaging
- Cellular Biology
Background:
- 19F MRI offers advantages for cell tracking compared to iron-based methods.
- Preclinical 19F cell tracking has been limited to high magnetic field strengths (>3 T).
- 19F MRI can serve as an imaging biomarker for tumor aggressiveness by detecting macrophages.
Purpose of the Study:
- To develop methods for 19F MRI cell tracking in mice using a 3 T clinical scanner.
- To assess the feasibility of detecting and quantifying 19F-labeled macrophages in tumors at 3 T.
Main Methods:
- Perfluorocarbon (PFC)-labeled macrophages were imaged at 3 T.
- 19F spin quantification was validated using NMR spectroscopy.
- In vivo 19F MRI was performed on tumor-bearing mice at 9.4 T and 3 T, with varying NEX at 3 T.
Main Results:
- Detection of as few as 25,000 cells in cell pellets at 3 T.
- 19F quantification in cell pellets by 3 T MRI correlated well with NMR spectroscopy.
- 19F signal was consistently observed in the liver, spleen, and tumor in all mice at both 9.4 T and 3 T, with no significant difference in spin quantification.
Conclusions:
- This study successfully demonstrates the detection and quantification of 19F signal in murine tumors using 19F MRI at 3 T.
- 19F MRI at 3 T is a viable method for preclinical cell tracking, particularly for macrophage detection in tumors.
Related Concept Videos
Preclinical Development: Overview
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Piaget's Stage 3 of Cognitive Development
Conservation and Constancy of Quantity
A significant cognitive milestone in the...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

